Skip to content

This website uses cookies

This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy.

Learn more

What to expect

Follow-up care visualization post-treatment for Neuroendocrine Tumors (NET).

What to expect

Every NET is different and many patients are presented with a confusing picture of NETs. NETs are an unusual type of cancer, so many doctors may not have seen a patient with NET before and may not know how to manage this type of cancer. This can be a challenging time. You may feel uncomfortable asking for a second opinion from a NET specialist. However, doctors are usually aware that deciding on a clinically suitable treatment plan may require the input from other healthcare professionals.

NET care is patient-specific and varies according to the patient’s medical history and type of NET. Patients with NET should have access to a specialized multidisciplinary team, made up of specialists who work together to manage NET treatment (see figure). Several studies have demonstrated that long-term outcomes improve when patients with NET are treated by multidisciplinary teams.1 Moreover, international guidelines recommend patients seek treatment by NET-dedicated multidisciplinary teams, even if specialized centers are not the most convenient or the closest to their homes.

.
NET is a complex disease, and successful care and treatment can require the input of many specialists.
"Who will be involved in my care?"

Back to overview Questions to ask your doctor
You’re now leaving the website myNETjourney.com
This link is provided for information purposes only. Please be aware that, if you click on it, you will leave myNETjourney.com website. The link will take you to a website owned and operated by an independent party over which ITM Oncologics GmbH has no control or influence (“third-party website”).
ITM Oncologics GmbH makes no representation that information on the third-party website is appropriate or available for use or access in locations outside the country for which the third-party website is intended. Therefore, ITM Oncologics GmbH declines any responsibility for third-party information. ITM Oncologics GmbH makes no representation regarding the data usage policies of the third party website and declines any responsibility for the use of personal data by the operator of the third-party website. Please ensure that you belong to the intended audience of the content provided on third-party website and that your access to it complies with the applicable laws and regulations.
 
Do you really want to leave the myNETjourney.com website?
Welcome to myNETjourney.com
In order to provide you with information tailored to your needs, we kindly ask you to select one of the following: